Data / Drug companies / Chain Drug Consortium, LLC
Chain Drug Consortium, LLC: 124 products in the FDA NDC directory, labeler code 68016
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chain Drug Consortium, LLC (labeler code 68016) lists 124 products in the FDA National Drug Code Directory, covering 75 finished drugs by generic name. By type: 124 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 31, 2023.
The request: Watch Chain Drug Consortium, LLC (FDA labeler code 68016): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 68016
- Products in commercial distribution
- 124
- Packages
- 166
- Finished drugs by generic name
- 75
- Prescription products
- 0
- Over the counter products
- 124
- Flagged as original packager
- 121 of 121 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 33
- Earliest marketing start
- August 25, 1981
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 83 | 66.9% |
| Generic drugs (ANDA) | 33 | 26.6% |
| Other unapproved drugs | 5 | 4% |
| New drug applications (NDA) | 2 | 1.6% |
| Unapproved homeopathic products | 1 | 0.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 124 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 16 | 12.9% |
| Liquid | 13 | 10.5% |
| Tablet, chewable | 13 | 10.5% |
| Gum, chewing | 10 | 8.1% |
| Ointment | 7 | 5.6% |
| Cream | 7 | 5.6% |
| Capsule, liquid filled | 6 | 4.8% |
| Solution | 6 | 4.8% |
| Kit | 5 | 4% |
| Lozenge | 5 | 4% |
| Suppository | 4 | 3.2% |
| Tablet, film coated | 4 | 3.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Premier Value | 68016-886 | Lozenge | Over the counter monograph drugs | July 31, 2023 |
| Premier Value | 68016-885 | Lozenge | Over the counter monograph drugs | July 31, 2023 |
| Premier Value | 68016-884 | Lozenge | Over the counter monograph drugs | July 31, 2023 |
| Premier Value | 68016-883 | Lozenge | Over the counter monograph drugs | July 31, 2023 |
| Benzalkonium chloride | 68016-866 | Liquid | Over the counter monograph drugs | June 29, 2023 |
| Arthritis Pain Reliever | 68016-171 | Gel | Generic drugs (ANDA) | December 31, 2022 |
| Ibuprofen | 68016-813 | Capsule, liquid filled | Generic drugs (ANDA) | August 26, 2022 |
| Pain Reliever | 68016-543 | Tablet, film coated | Over the counter monograph drugs | April 29, 2022 |
| Soft Tip Squeeze bottle Sinus Wash Premier Value | 68016-452 | Kit | Other unapproved drugs | January 9, 2022 |
| Soft Tip Neti Pot Easy to use Sinus Relief Premier Value | 68016-451 | Kit | Other unapproved drugs | January 9, 2022 |
| Famotidine | 68016-801 | Tablet | Generic drugs (ANDA) | November 1, 2021 |
| Famotidine | 68016-800 | Tablet | Generic drugs (ANDA) | November 1, 2021 |
| Premier Value Milk of Magnesia | 68016-850 | Suspension | Over the counter monograph drugs | June 2, 2021 |
| Cold Sore Fever Blister Treatment | 68016-344 | Cream | Generic drugs (ANDA) | June 1, 2021 |
| Stool Softener Extra Strength | 68016-587 | Capsule, liquid filled | Over the counter monograph drugs | April 30, 2021 |
| Pain Reliever | 68016-734 | Tablet, coated | Over the counter monograph drugs | March 29, 2021 |
| Premier Value | 68016-809 | Swab | Over the counter monograph drugs | January 1, 2021 |
| Premier Value Lice Treatment Kit | 68016-552 | Kit | Over the counter monograph drugs | December 9, 2020 |
| Lice Killing | 68016-253 | Shampoo | Over the counter monograph drugs | October 12, 2020 |
| Premier Value Instant Antiseptic Pain Relief | 68016-821 | Liquid | Over the counter monograph drugs | January 30, 2020 |
| Premiere Value Ear Drops for Swimmers | 68016-820 | Liquid | Over the counter monograph drugs | January 30, 2020 |
| PV Extra Strength Antacid | 68016-700 | Tablet, chewable | Over the counter monograph drugs | January 20, 2020 |
| Hydrocortisone | 68016-529 | Cream | Over the counter monograph drugs | January 9, 2020 |
| Hydrocortisone | 68016-149 | Cream | Over the counter monograph drugs | January 9, 2020 |
| Premier Value Bacitracin Zinc | 68016-107 | Ointment | Over the counter monograph drugs | December 16, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.